Published in PLoS One on September 11, 2012
Menstrual cycle length: a surrogate measure of reproductive health capable of improving the accuracy of biochemical/sonographical ovarian reserve test in estimating the reproductive chances of women referred to ART. Reprod Biol Endocrinol (2015) 0.84
Ongoing pregnancy rates in women with low and extremely low AMH levels. A multivariate analysis of 769 cycles. PLoS One (2013) 0.81
Antimüllerian hormone among women with and without type 1 diabetes: the Epidemiology of Diabetes Interventions and Complications Study and the Michigan Bone Health and Metabolism Study. Fertil Steril (2016) 0.80
Recombinant LH supplementation during IVF cycles with a GnRH-antagonist in estimated poor responders: A cross-matched pilot investigation of the optimal daily dose and timing. Mol Med Rep (2015) 0.79
Ovarian reserve in women with Type 1 diabetes in the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study. Diabet Med (2016) 0.78
Anti-Müllerian hormone levels as a predictor of clinical pregnancy in in vitro fertilization/intracytoplasmic sperm injection-embryo transfer cycles in patients over 40 years of age. Clin Exp Reprod Med (2015) 0.77
The role of serum AMH and FF AMH in predicting pregnancy outcome in the fresh cycle of IVF/ICSI: a meta-analysis. Int J Clin Exp Med (2015) 0.77
Salpingectomy before assisted reproductive technologies: a systematic literature review. J Ovarian Res (2016) 0.75
Effect of anti-Mullerian hormone in culture medium on quality of mouse oocytes matured in vitro. PLoS One (2014) 0.75
Awareness of the effects of postponing motherhood among hospital gynecologists: is their knowledge sufficient to offer appropriate help to patients? J Assist Reprod Genet (2016) 0.75
Pretreatment with oral contraceptive pills to identify poor responders that may benefit from rLH supplementation during GnRH-antagonist treatment for IVF: A pilot perspective study proposal. Exp Ther Med (2015) 0.75
A systematic review of tests predicting ovarian reserve and IVF outcome. Hum Reprod Update (2006) 4.24
Factors that affect outcome of in-vitro fertilisation treatment. Lancet (1996) 4.13
Fertility, family planning, and women's health: new data from the 1995 National Survey of Family Growth. Vital Health Stat 23 (1997) 3.75
Serum anti-Müllerian hormone levels: a novel measure of ovarian reserve. Hum Reprod (2002) 3.59
Anti-Müllerian hormone expression pattern in the human ovary: potential implications for initial and cyclic follicle recruitment. Mol Hum Reprod (2004) 3.57
Anti-Müllerian hormone levels in the spontaneous menstrual cycle do not show substantial fluctuation. J Clin Endocrinol Metab (2006) 3.13
Antimüllerian hormone serum levels: a putative marker for ovarian aging. Fertil Steril (2002) 3.03
Serum antimullerian hormone levels best reflect the reproductive decline with age in normal women with proven fertility: a longitudinal study. Fertil Steril (2005) 2.90
Regulation of ovarian function: the role of anti-Müllerian hormone. Reproduction (2002) 2.80
Anti-müllerian hormone is a promising predictor for the occurrence of the menopausal transition. Menopause (2004) 2.69
Serum anti-Mullerian hormone throughout the human menstrual cycle. Hum Reprod (2006) 2.37
Serum anti-Müllerian hormone is more strongly related to ovarian follicular status than serum inhibin B, estradiol, FSH and LH on day 3. Hum Reprod (2003) 2.30
Early follicular antimüllerian hormone as an indicator of ovarian reserve. Fertil Steril (2006) 2.29
Anti-mullerian hormone and inhibin B in the definition of ovarian aging and the menopause transition. J Clin Endocrinol Metab (2008) 2.27
Anti-Müllerian hormone inhibits initiation of primordial follicle growth in the mouse ovary. Endocrinology (2002) 2.25
Anti-Müllerian hormone measurement on any day of the menstrual cycle strongly predicts ovarian response in assisted reproductive technology. Hum Reprod (2006) 1.87
Serum antimüllerian hormone/müllerian-inhibiting substance appears to be a more discriminatory marker of assisted reproductive technology outcome than follicle-stimulating hormone, inhibin B, or estradiol. Fertil Steril (2004) 1.81
Predictors of poor ovarian response in in vitro fertilization: a prospective study comparing basal markers of ovarian reserve. Fertil Steril (2002) 1.78
Antral follicle count, anti-mullerian hormone and inhibin B: predictors of ovarian response in assisted reproductive technology? BJOG (2005) 1.71
Anti-Müllerian hormone (AMH) in female reproduction: is measurement of circulating AMH a useful tool? Clin Endocrinol (Oxf) (2006) 1.68
Anti-müllerian hormone and anti-müllerian hormone type II receptor messenger ribonucleic acid expression in rat ovaries during postnatal development, the estrous cycle, and gonadotropin-induced follicle growth. Endocrinology (1995) 1.66
Expression of the mouse anti-müllerian hormone gene suggests a role in both male and female sexual differentiation. Development (1991) 1.57
Anti-mullerian hormone as a marker of ovarian reserve. Aust N Z J Obstet Gynaecol (2005) 1.51
Anti-Müllerian hormone plasma levels in spontaneous menstrual cycle and during treatment with FSH to induce ovulation. Hum Reprod (2004) 1.48
Use of the antral follicle count to predict the outcome of assisted reproductive technologies. Fertil Steril (1998) 1.48
Reproductive aging: accelerated ovarian follicular development associated with a monotropic follicle-stimulating hormone rise in normal older women. J Clin Endocrinol Metab (1996) 1.47
Dynamic assays of inhibin B, anti-Mullerian hormone and estradiol following FSH stimulation and ovarian ultrasonography as predictors of IVF outcome. Hum Reprod (2005) 1.42
Expression of anti-Müllerian hormone during normal and pathological gonadal development: association with differentiation of Sertoli and granulosa cells. J Clin Endocrinol Metab (1999) 1.29
Inhibin B and anti-Mullerian hormone: markers of ovarian response in IVF/ICSI patients? BJOG (2004) 1.29
Age-dependent decrease in embryo implantation rate after in vitro fertilization. Fertil Steril (1996) 1.27
Evaluation of anti-Müllerian hormone as a test for the prediction of ovarian reserve. Fertil Steril (2007) 1.24
Trends in pregnancy rates for the United States, 1976-97: an update. Natl Vital Stat Rep (2001) 1.07
Anti-Müllerian hormone levels in serum from human foetuses and children: pattern and clinical interest. Mol Cell Endocrinol (2003) 1.06
Anti-Müllerian hormone is a specific marker of sertoli- and granulosa-cell origin in gonadal tumors. Hum Pathol (2000) 1.04
Antimüllerian hormone as a serum marker of granulosa cell tumorsof the ovary: comparative study with serum alpha-inhibin and estradiol. Am J Obstet Gynecol (1996) 1.02
Anti-Mullerian hormone in premenopausal women and after spontaneous or surgically induced menopause. J Soc Gynecol Investig (2005) 0.99
Follicle-stimulating hormone increases testicular Anti-Mullerian hormone (AMH) production through sertoli cell proliferation and a nonclassical cyclic adenosine 5'-monophosphate-mediated activation of the AMH Gene. Mol Endocrinol (2003) 0.97
Basal follicle-stimulating hormone levels are of limited value in predicting ongoing pregnancy rates after in vitro fertilization. Fertil Steril (2000) 0.97
Detection of minimal levels of serum anti-Müllerian hormone during follow-up of patients with ovarian granulosa cell tumor by means of a highly sensitive enzyme-linked immunosorbent assay. J Clin Endocrinol Metab (2000) 0.96
Mullerian inhibiting substance in the adult rat ovary during various stages of the estrous cycle. Endocrinology (1989) 0.93
The ontogeny of mullerian inhibiting substance in granulosa cells of the bovine ovarian follicle. Biol Reprod (1986) 0.89
Dynamics of serum anti-Müllerian hormone levels during the luteal phase of controlled ovarian hyperstimulation. Hum Reprod (2004) 0.83
Müllerian inhibiting substance gene expression in the cycling rat ovary correlates with recruited or graafian follicle selection. Biol Reprod (1994) 0.82
Evaluation of functional ovarian reserve in 60 patients. Reprod Biomed Online (2003) 0.82
Maternal hydration therapy improves the quantity of amniotic fluid and the pregnancy outcome in third-trimester isolated oligohydramnios: a controlled randomized institutional trial. J Ultrasound Med (2012) 2.07
Extragenital Müllerian adenosarcoma with pouch of Douglas location. BMC Cancer (2011) 1.19
CA 125 serum values in surgically treated endometriosis patients and its relationships with anatomic sites of endometriosis and pregnancy rate. Fertil Steril (2010) 1.18
Cervical Mullerian adenosarcoma with heterologous sarcomatous overgrowth: a fourth case and review of literature. BMC Cancer (2011) 1.15
"Empiric" inositol supplementation in normal-weight non insulin resistant women with polycystic ovarian disease: from the absence of benefit to the potential adverse effects. Arch Gynecol Obstet (2015) 1.07
Update on best available options in obstetrics anaesthesia: perinatal outcomes, side effects and maternal satisfaction. Fifteen years systematic literature review. Arch Gynecol Obstet (2014) 0.92
Dedifferentiated endometrial cancer: an atypical case diagnosed from cerebellar and adrenal metastasis: case presentation and review of literature. Int J Clin Exp Pathol (2013) 0.89
Calcium supplementation and prevention of preeclampsia: a meta-analysis. J Matern Fetal Neonatal Med (2012) 0.89
Fertility preservation in young women with cervical cancer: an oncologic dilemma or a new conception of fertility sparing surgery? Cancer Invest (2013) 0.88
Limits and complications of laparoscopic myomectomy: which are the best predictors? A large cohort single-center experience. Arch Gynecol Obstet (2014) 0.88
High-risk human papillomavirus DNA test: could it be useful in low-grade cervical lesion triage? Five-year follow-up. Reprod Sci (2013) 0.87
Risk of preterm delivery associated with prior treatment of cervical precancerous lesion according to the depth of the cone. Dis Markers (2013) 0.87
Secondary Müllerian system: an atypical case of tumor originating from vestigial Müllerian cells embedded in the peritoneum. Clin Genitourin Cancer (2013) 0.86
Endometrial polyps in women affected by levothyroxine-treated hypothyroidism--histological features, immunohistochemical findings, and possible explanation of etiopathogenic mechanism: a pilot study. Biomed Res Int (2013) 0.85
Prophylactic bilateral salpingectomy for the prevention of ovarian cancers: What is happening in Italy? Eur J Cancer Prev (2016) 0.85
Endometrial surveillance in tamoxifen users: role, timing and accuracy of hysteroscopic investigation: observational longitudinal cohort study. Endocr Relat Cancer (2013) 0.84
Could kidney glomerular filtration impairment represent the "Achilles heel" of HE4 serum marker? A possible further implication. Clin Chem Lab Med (2014) 0.83
Ultrasound investigation during labour of consensual or nonconsensual fetal spine in an occiput posterior cephalic presentation can improve the management of delivery? Ultrasound Med Biol (2012) 0.82
Conservative treatment for interstitial monochorionic twin pregnancy: case report and review of the published work. J Obstet Gynaecol Res (2013) 0.81
Human papillomavirus detection and genotyping on pelvic nodes in patients with synchronous gynecological malignancies: a tool for identifying the primary site of lymphatic spread? Int J Gynecol Cancer (2010) 0.81
Effects of raloxifene and continuous combined hormone therapy on haemostasis variables: a multicenter, randomized, double-blind study. Thromb Res (2006) 0.81
Ghrelin inhibits steroid biosynthesis by cultured granulosa-lutein cells. J Clin Endocrinol Metab (2008) 0.81
LH supplementation in down-regulated women undergoing assisted reproduction with baseline low serum LH levels. Gynecol Endocrinol (2010) 0.80
[Onychomadesis associated with mouth, hand and foot disease]. Arch Argent Pediatr (2013) 0.80
Craniosynostosis: prenatal diagnosis by means of ultrasound and SSSE-MRI. Family series with report of neurodevelopmental outcome and review of the literature. Arch Gynecol Obstet (2010) 0.80
Pharmacological anti-thrombotic prophylaxis after elective caesarean delivery in thrombophilia unscreened women: should maternal age have a role in decision making? J Perinat Med (2014) 0.80
Total laparoscopic hysterectomy: our experience from 2008 to 2012. Ann Ital Chir (2014) 0.79
[Rhabdomyoma of the vagina. Case report and short literature review]. Ann Pathol (2012) 0.79
Usefulness, methods and rationale of lymph nodes HPV-DNA investigation in estimating risk of early stage cervical cancer recurrence: a systematic literature review. Clin Exp Metastasis (2014) 0.79
Can the impact of pelvic inflammatory disease on fertility be prevented? Epidemiology, clinical features and surgical treatment: evolution over 8 years. J Reprod Med (2013) 0.79
Profound luteinizing hormone suppression induces a deleterious follicular environment during assisted reproduction technology. Fertil Steril (2003) 0.79
Wernicke's encephalopathy complicating hyperemesis gravidarum: from the background to the present. J Matern Fetal Neonatal Med (2011) 0.79
Uncertainties about laparoscopic myomectomy during pregnancy: A lack of evidence or an inherited misconception? A critical literature review starting from a peculiar case. Minim Invasive Ther Allied Technol (2014) 0.79
Thanatophoric dysplasia type I associated with increased nuchal translucency in the first trimester: Early prenatal diagnosis using combined ultrasonography and molecular biology. Fetal Pediatr Pathol (2010) 0.78
Role of D-dimer testing in severe pelvic inflammatory disease: a new usable marker to assess the need for fertility-impairing surgery? Fertil Steril (2010) 0.78
Could molecular assessment of calcium metabolism be a useful tool to early screen patients at risk for pre-eclampsia complicated pregnancy? Proposal and rationale. Clin Chem Lab Med (2015) 0.78
Choledocholithiasis and endo-laparoscopic rendezvous. Analysis of 59 consecutive cases. Ann Ital Chir (2011) 0.78
Subtotal versus total laparoscopic hysterectomy: could women sexual function recovery overcome the surgical outcomes in pre-operatory decision making? Arch Gynecol Obstet (2014) 0.78
Is CD10 a reliable marker of invasive colorectal cancer? Ann Ital Chir (2011) 0.77
Is it time to consider patients suffering from endometriosis-related infertility as "novel candidates" for targeted peri-conceptional D-chiro inositol supplementation? Hypothesis, rationale and some considerations. J Assist Reprod Genet (2014) 0.77
Lipophilic Statins as Anticancer Agents: Molecular Targeted Actions and Proposal in Advanced Gynaecological Malignancies. Curr Drug Targets (2015) 0.77
A prospective, case-control study on the lipid profile and the cardiovascular risk of menopausal women on oestrogen plus progestogen therapy in a northern Italy province. Arch Gynecol Obstet (2013) 0.77
Obstetric dilemma on the most appropriate management of Creutzfeldt-Jakob disease in pregnancy: seventh case presentation, literature review and new insight. J Matern Fetal Neonatal Med (2014) 0.77
Gonadotropin-releasing hormone antagonists increase follicular fluid insulin-like growth factor-I and vascular endothelial growth factor during ovarian stimulation cycles. Gynecol Endocrinol (2006) 0.76
Reply: To PMID 22298867. J Ultrasound Med (2014) 0.76
Squamotransitional cell carcinoma of the vagina: diagnosis and clinical management: a literature review starting from a rare case report. Pathol Oncol Res (2010) 0.76
Ulipristal acetate: critical review about endometrial and ovulatory effects in emergency contraception. Reprod Sci (2014) 0.76
Complex cardiac defect, bowing of lower limbs and multiple anomalies in trisomy 22. Ultrasound, post-mortem CT findings with necropsy confirmation. Fetal Pediatr Pathol (2012) 0.75
Could HPV-DNA test solve the dilemma about sentinel node frozen section accuracy in early stage cervical cancer? Hypothesis and rationale. Cancer Invest (2014) 0.75
The role of ultrasound and antenatal single-shot fast spin-echo MRI in the evaluation of herniated bowel in case of first trimester ultrasound diagnosis of fetal gastroschisis. Arch Gynecol Obstet (2010) 0.75
Two case reports of bowel leiomyomas and review of literature. Gynecol Endocrinol (2010) 0.75
Successful laparoscopic management of adnexal torsion during week 15 of a single pregnancy. J Minim Invasive Gynecol (2010) 0.75
Massive ascites and hydrothorax after leuprolide acetate administration in a down-regulated woman undergoing assisted reproduction. Fertil Steril (2007) 0.75
Quality of life in patients affected by endometrial cancer: comparison among laparotomy, laparoscopy and vaginal approach. Pathol Oncol Res (2015) 0.75
Laparoscopic proctocolectomy: analysis of long term complications. Case report. Ann Ital Chir (2011) 0.75
Cyclic variations of bone resorption mediators and markers in the different phases of the menstrual cycle. J Bone Miner Metab (2013) 0.75
Can we define a role for perisentinel lymph-nodes on breast cancer disease? Ann Ital Chir (2011) 0.75